Fact CheckerSign in

NCT07456956Recruiting

HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke

The Effect of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training on Sarcopenia and Clinical Outcomes in Patients With Ischemic Stroke: A Single-Blind Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

The aim of this study is to investigate the effect of post-stroke sarcopenia on prognosis and clinical outcomes in patients with ischemic stroke and to compare the effects of High Intensity Interval Training (HIIT) and Moderate Intensity Continuous Training (MCIT) exercise programs on muscle mass, as well as on functional capacity, quality of life, and clinical outcomes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
32 (estimated)
First submitted
3 Mar 2026
Start date
2 Mar 2026
Primary completion date
6 Apr 2027
Lead sponsor
Fenerbahce University
Diseases
Stroke
NCT number
NCT07456956

What you commit to

  • Study type: Interventional
  • Planned participants: 32
  • From 2 Mar 2026 to the primary completion date, 6 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of recurrent stroke.
  • Presence of a psychiatric disorder.
  • Presence of orthopedic, neurological, or cardiopulmonary conditions that would contraindicate the planned exercise protocols.

Other

  • Presence of hemispatial neglect.

Who the study is looking for

  • First-ever stroke.
  • Age 18 years or older.
  • Diagnosis of ischemic stroke.
  • Stroke duration between 1-6 months (subacute phase).
  • Modified Rankin Scale score \< 3.
  • Mini-Mental State Examination (MMSE) score ≥ 24.
  • Brunnstrom lower extremity motor stage between Stage III-V.
  • Lower extremity functional capacity sufficient to allow exercise participation (able to ambulate at least with an assistive device).
  • Lower extremity spasticity ≤ 2 according to the Modified Ashworth Scale.
  • Independent sitting balance (able to sit unsupported for at least 30 seconds).
  • Presence of sufficient voluntary active movement in the lower extremity to permit exercise application.
  • Ability to communicate.
  • Willingness to participate in the study and provision of written informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fenerbahçe University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.